General Information of Drug (ID: DM74GWO)

Drug Name
4-Carbazol-9-yl-butyric acid Drug Info
Synonyms
CARBAZOLE BUTANOIC ACID; 4-(9H-CARBAZOL-9-YL)BUTANOIC ACID; CHEMBL185595; CRZ; 90053-09-1; 4-Carbazol-9-yl-butyric acid; 1tow; AC1L9MBO; 4-carbazol-9-ylbutanoic acid; 9H-Carbazole-9-butanoic acid; SCHEMBL4314440; 4-(N-carbazolyl) butyric acid; CTK3I5050; DTXSID50332287; BDBM50152851; AKOS000153937
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
448769
CAS Number
CAS 90053-09-1
TTD Drug ID
DM74GWO

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
PMID27109571-Compound-27 DMXRTH4 N. A. N. A. Patented [2]
PMID27109571-Compound-31 DMU690T N. A. N. A. Patented [2]
PMID27109571-Compound-16 DMZI25U N. A. N. A. Patented [2]
PMID27109571-Compound-14 DMVY6B9 N. A. N. A. Patented [2]
PMID27109571-Compound-25 DM435GR N. A. N. A. Patented [2]
PMID27109571-Compound-30 DM24FSP N. A. N. A. Patented [2]
PMID27109571-Compound-29 DMDMEHQ N. A. N. A. Patented [2]
PMID27109571-Compound-18 DM4S5ME N. A. N. A. Patented [2]
PMID27109571-Compound-28 DMTZVY3 N. A. N. A. Patented [2]
PMID27109571-Compound-20 DMQU9XP N. A. N. A. Patented [2]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
PMID27109571-Compound-27 DMXRTH4 N. A. N. A. Patented [2]
PMID27109571-Compound-31 DMU690T N. A. N. A. Patented [2]
PMID27109571-Compound-16 DMZI25U N. A. N. A. Patented [2]
PMID27109571-Compound-14 DMVY6B9 N. A. N. A. Patented [2]
PMID27109571-Compound-25 DM435GR N. A. N. A. Patented [2]
PMID27109571-Compound-30 DM24FSP N. A. N. A. Patented [2]
PMID27109571-Compound-29 DMDMEHQ N. A. N. A. Patented [2]
PMID27109571-Compound-18 DM4S5ME N. A. N. A. Patented [2]
PMID27109571-Compound-28 DMTZVY3 N. A. N. A. Patented [2]
PMID27109571-Compound-20 DMQU9XP N. A. N. A. Patented [2]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Fatty acid-binding protein 4 (FABP4) TTHWMFZ FABP4_HUMAN Inhibitor [1]
Fatty acid-binding protein 5 (FABP5) TTNT2S6 FABP5_HUMAN Inhibitor [1]

References

1 Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target. Bioorg Med Chem Lett. 2004 Sep 6;14(17):4445-8.
2 Fatty acid binding protein (FABP) inhibitors: a patent review (2012-2015).Expert Opin Ther Pat. 2016 Jul;26(7):767-76.